Picture this: a family member collapses at home. Panic sets in. Someone grabs a phone and starts calling — one ambulance number leads to a busy tone, another quotes an unaffordable price, a third doesn’t have the right equipment. By the time the right vehicle arrives, twenty minutes have passed. In a medical emergency, that is twenty minutes no one can afford to lose.

This is not a hypothetical. It is the everyday reality for millions of Mumbai residents navigating a broken, fragmented emergency transport system. The city has ambulances but finding the right one, at the right time, at a fair price, has always been the problem.

AIVA Health was built to fix exactly that.

Operating across all of Mumbai, AIVA Health is a single, trusted platform that connects patients and families with verified ambulance services instantly. Whether you need a basic transport vehicle, an ICU-equipped ambulance, ventilator support, or a patient transfer arrangement, AIVA handles it through one point of contact with confirmed booking, transparent pricing, and minimal wait time.

No more calling five numbers. No more haggling on price while someone you love needs help. No more uncertainty about whether the vehicle that shows up will have what the patient actually needs.

“In a medical emergency, families shouldn’t be negotiating at all. We built AIVA so that one call is enough.”

What sets AIVA apart from a simple directory or referral service is its commitment to both sides of the equation. For patients, it means reliability and fairness. For ambulance operators and providers, it means a platform that respects their work — offering fair earnings without the heavy commission cuts that have long made this industry unsustainable for smaller operators.

The platform currently covers every corner of Mumbai from the dense urban corridors of South Mumbai to the outer suburbs and beyond. And while the immediate focus remains on delivering a dependable service within the city, the vision is larger: a pan-India network that brings the same reliability to tier-2 cities, rural districts, and underserved regions where ambulance access is either limited or entirely absent.

India loses thousands of lives each year simply due to delays in emergency transport. Not because of a lack of technology or resources, but because of a lack of coordination.

AIVA Health is not trying to reinvent the ambulance it is building the infrastructure that makes the ones we already have actually work.

Book an ambulance now — visit www.aivahealth.in or call 7400194039

In a city like Mumbai, where every minute on the road matters, that is not a small thing. That is the difference between a life lost and a life saved.

To book an ambulance or learn more, visit www.aivahealth.in | Available across all of Mumbai | All ambulance types covered

The post AIVA Health Mumbai Instant Ambulance Booking Platform Saving Lives in Emergencies appeared first on The India Bizz Startup News Website.

The post AIVA Health Mumbai Instant Ambulance Booking Platform Saving Lives in Emergencies appeared first on The India Bizz Startup News Website.

The post Hims Shakes Up US Weight-Loss Market With Cheapest GLP-1 Pill appeared first on The India Bizz Startup News Website.

Top 10 Startups Transforming Healthcare (detailed profiles)

Intro: Healthcare innovation is racing ahead across diagnostics, care delivery, clinical workflows, and consumer health. Below are ten startups a mix of clinical AI pioneers, data platforms, telehealth leaders and digital-care marketplaces that are shaping the future of medicine today.

1) Tempus — AI + genomics for precision oncology

What they do: Combines large clinical and molecular datasets with AI to deliver precision-medicine tools for oncology (genomic testing, clinical decision support, clinical-trial matching).
Why it matters: Tempus is scaling genomics and AI into routine oncology workflows and publishing clinical research; it has expanded via acquisitions (e.g., digital pathology) and strategic partnerships.
Notable: Public company activity, strong revenue growth in genomics and partnerships with large healthcare groups.

2) GRAIL — multi-cancer early detection (liquid biopsy)

What they do: Developing blood-based multi-cancer early detection tests (Galleri®) using cfDNA methylation and machine learning to screen for many cancers from a single test.
Why it matters: Early detection through minimally invasive tests could shift cancer outcomes at population scale; GRAIL’s clinical data and presentations continue to shape the MCED field.

3) Viz.ai — AI workflow and care coordination (formerly stroke, now oncology & more)

What they do: AI-driven image analysis + workflow orchestration to accelerate diagnosis and coordinate care across acute conditions (stroke, emergent radiology) — recently expanding into oncology workflows.
Why it matters: Improves time-sensitive care coordination and has secured clinician adoption and industry recognition; Viz.ai also earned top rankings in acute-care AI surveys.

4) Suki — AI voice assistants to reduce clinician administrative burden

What they do: Develops AI voice-assistant and ambient scribing tools that automate clinical documentation and reduce physician administrative time.
Why it matters: Cutting documentation time increases clinician productivity and can improve clinician experience and patient throughput; Suki has raised significant funding to scale these tools.

5) Innovaccer — healthcare-data activation & population health cloud

What they do: A healthcare intelligence platform that ingests and normalizes fragmented clinical, claims and operational data to power population health, analytics and care-management workflows.
Why it matters: Data unification is foundational to value-based care, population health and AI — Innovaccer positions itself as the “data layer” for health systems. The company has raised large funding rounds to expand its cloud platform.

6) Doximity — professional network + workflow tools for clinicians

What they do: The leading digital network for U.S. physicians that also offers workflow tools (telehealth, secure communication, medical news, hiring) and growing AI features for clinicians.
Why it matters: High clinician penetration (majority of U.S. physicians) makes Doximity an important distribution and engagement channel for clinical tools, education and recruitment.

7) Navina Health — AI copilot for clinics and EHR workflows

What they do: AI platform that extracts clinical insights from EHRs to aid coding, billing, clinical decision support and documentation (an AI “copilot” for ambulatory practices).
Why it matters: Automating routine EHR tasks reduces admin burden and supports value-based care; Navina recently raised growth funding and has strong clinic adoption.

8) Qure.ai — AI diagnostics for imaging (India → global)

What they do: Deep-learning solutions for radiology and chest X-ray/CT interpretation (TB, lung nodules, stroke), with multiple FDA clearances and global deployments.
Why it matters: Qure.ai’s tools aim to close diagnostic gaps in low-resource settings and support early detection (notably lung cancer and TB); the company earned major recognitions and is eyeing an IPO.

9) Practo — India’s large digital health platform (telemedicine + marketplace)

What they do: End-to-end digital healthcare services: doctor discovery, teleconsultations, diagnostics, electronic health records and a marketplace for health services.
Why it matters: Practo is a flagship Indian healthtech platform that has recently shown path to profitability and is preparing for larger public market moves — a key example of consumer digital health at scale in Asia.

10) PharmEasy (API Holdings) — online pharmacy & diagnostics marketplace (India)

What they do: Online pharmacy, diagnostics bookings, and healthcare marketplace connecting patients to pharmacies and labs across India.
Why it matters: PharmEasy drives access to medicines and preventive care at scale in India; its large data footprint and consumer reach make it central to digital health distribution despite some recent leadership and financial restructuring.

The post Top 10 Healthcare Startups Transforming the Medical Industry in 2025 appeared first on The India Bizz Startup News Website.

The post Top 10 Healthcare Startups Transforming the Medical Industry in 2025 appeared first on The India Bizz Startup News Website.

She noted that the pandemic accelerated digital adoption by over 300%, proving the urgency of integrated healthcare models that ensure continuity of care and early interventions. She further stressed that technology must work in tandem with clinical excellence, ensuring that digital advancements do not replace but enhance the expertise of doctors, improve diagnostic precision, and standardize quality care across all touchpoints.

On technology’s role, she highlighted Apollo Hospitals’ strategic partnership with Microsoft, which focuses on developing AI-driven tools to improve diagnosis, treatment planning, and patient monitoring. This collaboration spans disease progression analysis, genomics research, and AI-driven decision-making models aimed at enhancing clinical accuracy and patient outcomes.

Microsoft is assisting Apollo in data management and AI integration to create scalable solutions that reduce diagnostic delays, optimize hospital workflows, and improve remote healthcare delivery. The partnership has already identified four AI copilots—for clinicians, patients, nurses, and hospital operations—to support real-time decision-making and proactive care management.

Addressing affordability, she underscored Ayushman Bharat (PM-JAY), microinsurance models, and healthcare lending as essential in reducing financial barriers and ensuring quality care reaches Tier-2 cities and underserved communities. She emphasized that the future of healthcare lies in making advanced treatments both accessible and preventive, ensuring that cutting-edge innovations, combined with clinical expertise, help reduce the burden of disease before it escalates into crisis care.”

The post Dr. Sangita Reddy, Joint MD, Apollo Hospitals, on Integrated Healthcare at BioAsia 2025 appeared first on The India Bizz Startup News Website.

The post Dr. Sangita Reddy, Joint MD, Apollo Hospitals, on Integrated Healthcare at BioAsia 2025 appeared first on The India Bizz Startup News Website.

This partnership aligns with the Indian government’s Bio-E3 policy, aimed at establishing India as a global hub for bio-manufacturing and advancing Prime Minister’s vision of Atmanirbhar Bharat. The lab will serve as a catalyst for innovation, capacity building, and industry collaboration in the wellness sector while also fostering entrepreneurship.

The Centre of Excellence – Herbalife Plant Cell Fermentation Technology Lab, is focused on pioneering sustainable solutions for high-quality herbal raw materials and phytochemicals. The facility will be a center to produce sustainable herbal raw materials using plant cell fermentation technology, ensuring high-quality phytochemicals and drive innovation in nutraceuticals, cosmeceuticals, and Ayush formulations, contributing directly to the UN Sustainable Development Goals (SDG3 – Good Health & Well-Being).

The collaborative effort will leverage plant cell technology to enable vitro cultivation of medicinal plants under controlled conditions, ensuring year-round availability, purity, and bioactive consistency. In addition to this, Advanced bioreactor-based scaling will facilitate large-volume production in minimal space, overcoming land constraints and long harvesting cycles associated with traditional farming and the green extraction technologies will drive sustainability in bioactive compound production.

The Plant Cell Fermentation Technology Lab predominantly has 5 key focus areas, Innovative Research to handle R&D, translational research, and blue-sky projects; Sustainable Biomanufacturing to handle the scalable plant cell fermentation for herbal extracts; Technology-Driven Solutions in the silico screening for phytochemical discovery and repurposing; Conservation Efforts in the production of somatic embryos and plant materials for field cultivation of endangered medicinal species; and Ecosystem Engagement to support hackathons as well as accelerator programs to drive innovation.

Mr. Ajay Khanna, Managing Director, Herbalife India, said, “Herbalife is committed to drive innovation that contributes to sustainability. Our partnership with IIT Madras, yet again this year is an effort towards transforming the nutraceutical and wellness sectors. Herbalife Plant Cell Fermentation Technology Lab at IIT Madras will be a catalyst for innovation, capacity building, and enhance industry collaboration in the wellness sector. Aligned with India’s Bio-E3 Policy (2024) and the National Biotechnology Development

Strategy (2022-25), this initiative will position India as a leader in biomanufacturing while contributing to the Prime Minister’s vision of Atmanirbhar Bharat.”

Prof. Smitha Srivastava, Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, IIT Madras., said, “The Herbalife-IITM Plant Cell Fermentation Technology Lab represents a significant milestone in sustainable innovation. This state-of-the-art facility will drive pioneering research, foster academic training, and enable impactful technology development for industry applications. I sincerely thank Herbalife for their generous support and unwavering belief in this initiative. Together, we are poised to transform the landscape of plant cell fermentation, creating meaningful outcomes for science, industry, and society”.

Prof. Ashwin Mahalingam, Dean – Alumni & Corporate Relations, IIT Madras, said, “It is heartening to see the IITM-Herbalife partnership growing from one milestone to another. Through their support for the establishment of the Plant Cell Fermentation Technology Lab, Herbalife has emerged as a leader in the field of sustainable solutions for high-quality herbal raw materials and phytochemicals. This partnership has indeed come at the right time, not only for IITM and Herbalife but also for our nation’s goals towards a brighter, sustainable future”.

About Herbalife International India Private Ltd.

Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people’s lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed food products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

For more information, visit https://www.herbalife.com/en-in

The post Herbalife India collaborates with IIT Madras to Launch Plant Cell Fermentation Technology Lab appeared first on The India Bizz Startup News Website.

The post Herbalife India collaborates with IIT Madras to Launch Plant Cell Fermentation Technology Lab appeared first on The India Bizz Startup News Website.

Despite these hurdles, healthcare brands can still effectively engage their audience, raise awareness, and spread important health information by adopting the right strategies and maintaining strict adherence to guidelines. In this blog, we’ll explore the current landscape of digital healthcare marketing, discuss the key challenges, and highlight how healthcare brands can navigate these complexities while still achieving success.

1. Introduction: The Role of Digital Marketing in Healthcare

The healthcare industry has undergone a dramatic transformation in recent years, particularly in how patients interact with healthcare providers. Patients now turn to the internet to search for medical information, research conditions, book appointments, and even seek consultations via telemedicine platforms. Digital marketing has become an indispensable tool for healthcare organizations to build their brand, educate patients, and promote services.

However, with great opportunity comes great responsibility. Healthcare marketers must navigate strict advertising guidelines, privacy laws, and the potential for misinformation. In this blog, we’ll dive deep into the challenges faced by healthcare brands in digital marketing and provide actionable strategies to remain compliant while effectively engaging with patients.

2. Key Challenges in Healthcare Digital Marketing

A. Advertising Restrictions by Meta and Google

Digital advertising platforms like Meta and Google impose strict rules on healthcare-related ads. These guidelines are designed to protect patients and prevent the spread of misleading or harmful information.

• Meta: Meta restricts healthcare ads, particularly around medical conditions, unverified treatments, and products. Ads that feature exaggerated health claims, before-and-after images, or personal health stories must be carefully vetted. For instance, cosmetic surgery clinics cannot run ads with dramatic “before-and-after” images; instead, their ads must focus on education rather than promotion.
• Google: Google’s policies are similarly stringent, especially when it comes to pharmaceutical ads and healthcare providers offering treatments. Advertisers must often be certified by third-party organizations. In addition, healthcare marketers must adhere to specific rules based on location, with some ads needing country-specific certifications.

The global digital health market, which includes advertising, is expected to reach $508.8 billion by 2025, underscoring the growing importance of digital channels for healthcare brands. However, these advertising restrictions can limit how brands engage with potential patients.

B. Data Privacy and Compliance

Data privacy is a major concern in healthcare digital marketing. Regulations like HIPAA (Health Insurance Portability and Accountability Act) in the U.S., GDPR (General Data Protection Regulation) in the EU, and India’s DPDP Act impose strict rules on how healthcare brands collect, store, and use patient data.

• Consent is critical. Healthcare marketers cannot collect sensitive health information without explicit permission.
• Platforms like Google and Meta must be configured correctly to avoid violating privacy laws when tracking patient behavior through tools like Google Analytics and Facebook Pixel.

Example: A healthcare provider cannot use a Facebook Pixel to track a patient who has visited their website and expressed interest in a specific treatment unless the provider has clear consent.

C. The Spread of Misinformation

Misinformation in healthcare can have serious consequences. Social media platforms, blogs, and websites are often rife with false or misleading health claims. This presents a challenge for healthcare marketers who must ensure that their content is accurate and trustworthy.

• Google and Meta are increasingly vigilant in removing health-related content that violates their guidelines. Marketers need to ensure that the content they create is backed by reputable sources, such as peer-reviewed studies, medical experts, and organizations like the CDC or WHO.

Example: A brand promoting a new wellness DNA test would be prohibited from claiming it “confirms cancer” unless the claim is substantiated by clinical trials and approved by regulatory bodies.

D. SEO and Content Creation Challenges

SEO is critical for healthcare organizations aiming to increase visibility online. However, healthcare SEO faces unique challenges, particularly in terms of content competition and algorithm changes. Google’s E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) criteria are critical in determining which health-related content ranks well in search results.

3. Strategies for Engaging Audiences While Staying Compliant

A. Focus on Educational Content Marketing

Since traditional advertising options are often restricted, healthcare brands can thrive by focusing on educational content marketing. Instead of promoting products or services directly, healthcare organizations should create value-driven content that educates and informs patients.

B. Collaborating with Medical Professionals

Collaborating with medical professionals can enhance trust. Doctors, nurses, or well-known health influencers can share their expert advice on platforms like Instagram or YouTube.

C. Ethical Use of Email and WhatsApp Marketing

Email and WhatsApp marketing remain highly effective tools for healthcare brands. However, these channels must be used ethically, with explicit consent and personalised, valuable content.

• Example: A wellness brand might send monthly newsletters with health tips or special promotions, ensuring that every email is relevant and aligned with the recipient’s interests.

4. Conclusion: Moving Forward with Strategic Compliance

As the healthcare industry becomes more digitally engaged, the importance of staying compliant with advertising guidelines and privacy regulations grows. Navigating the digital marketing landscape can be challenging, but it also presents enormous opportunities for healthcare brands to engage with their audiences, build trust, and provide valuable health information.

By focusing on educational content, local SEO, collaborating with influencers, and ethical marketing practices, healthcare organizations can achieve sustainable success in the digital age while ensuring compliance with industry regulations.

5. GreyGiant – Your Trusted Digital Marketing Partner

At GreyGiant, we understand the complexities of digital marketing in the healthcare sector. With our expertise, we help healthcare organizations craft compliant, effective marketing strategies that connect with patients, build trust, and drive business growth.

Reach out to us today to discover how we can help you navigate the intricacies of healthcare digital marketing and elevate your brand’s presence while remaining compliant.

And don’t forget to check out the TIB Healthcare Awards!
Celebrate excellence in the healthcare sector, recognize outstanding contributions, and gain valuable industry insights. Join us in acknowledging the leaders of tomorrow’s healthcare marketing.

Reach out to us at vishal@theindiabizz..com

The post Navigating the Digital Marketing Landscape in Healthcare: Overcoming Challenges & Staying Compliant appeared first on The India Bizz Startup News Website.

The post Navigating the Digital Marketing Landscape in Healthcare: Overcoming Challenges & Staying Compliant appeared first on The India Bizz Startup News Website.

In June 2023, Healthify had already raised $30 million in a pre-Series D round, which included $5 million in venture debt. The company’s total equity financing to date now stands at $125 million.

The new capital will support Healthify’s ambitious plans for US expansion and enhance its AI-driven nutrition and fitness coaching capabilities, according to a press release from the company. These AI-powered features will be customized for new markets, like the US, with localization that includes language support, food preferences, and cultural adaptations.

Founded by Tushar Vashisht, Sachin Shenoy, and Mathew Cherian, Healthify combines software, wearable devices, and personalized fitness coaching to help its users achieve their health and fitness goals. With over 40 million users and a presence in 300 cities across India, Healthify is now gearing up to replicate its success in international markets.

In addition to its consumer app, Healthify has a growing B2B vertical that focuses on corporate wellness. The company has established partnerships with organizations in the diagnostics, insurance, and pharmaceutical sectors, aiming to provide comprehensive wellness solutions to businesses.

Financially, Healthify’s Indian operations have achieved operational profitability, and the company anticipates becoming EBITDA-positive by the end of this fiscal year. While the company has yet to file its annual report for FY24, it recorded Rs 229.71 crore in revenue for FY23, despite reporting a Rs 142 crore loss.

With its fresh capital, growing user base, and strong foothold in both B2C and B2B markets, Healthify is well-positioned to become a global leader in the health and wellness space, particularly with its forthcoming US expansion.

The post Healthify Raises $20M for US Expansion, Enhances AI Nutrition & Fitness Coaching appeared first on The India Bizz Startup News Website.

The post Healthify Raises $20M for US Expansion, Enhances AI Nutrition & Fitness Coaching appeared first on The India Bizz Startup News Website.

Founded in 2020 by Mayank Banerjee, Matilde Giglio, and Alessandro Ialongo, Even Healthcare has quickly gained momentum in transforming the healthcare landscape in India. The startup’s unique managed care model provides a comprehensive healthcare solution that covers both outpatient (OPD) and inpatient services, including unlimited free consultations, diagnostic tests, and cashless hospitalizations.

A Focus on Integrated Healthcare

What makes Even Healthcare stand out is its focus on integrated healthcare, offering more than just standard insurance coverage. Traditional insurance providers often limit coverage to hospitalization, leaving a gap in preventive and OPD services. Even fills this gap with its holistic approach, which covers preventive care, diagnostics, and OPD services, ensuring that members get well-rounded healthcare support.

Co-founder Matilde Giglio explained, “We do everything: prevention, diagnostics, and all the tests, including OPD, not just hospitalization.”

Expansion and Growth Plans

With the new funding, Even Healthcare plans to open three new hospitals in Bengaluru. These hospitals will focus on secondary care and aim to deliver a fully integrated healthcare experience. This expansion is part of the company’s broader mission to improve healthcare access and affordability across India.

In addition to expanding its hospital network, the startup is scaling its patient care processes by leveraging technology. Even Healthcare has already introduced an AI-powered health assistant named “Even Steven,” designed to help members better manage their healthcare needs.

Financial Growth and Market Impact

Even Healthcare has experienced significant financial growth since its commercial launch. The startup generated $9 million in revenue in the fiscal year 2023-24, and it expects to close the 2024-25 fiscal year with $35 million in revenue. With a workforce of 300 employees, the company serves a wide range of corporate clients, including Grant Thornton, Pixxel, Mensa, and Urban Ladder.

Investor Confidence

Vinod Khosla, founder of Khosla Ventures, praised the company’s efforts, stating, “Modernized healthcare is essential to any country. Even Healthcare is bringing high-quality, affordable care to one of the world’s largest populations, and we’re excited to partner with them as they boldly reimagine healthcare for India.”

This new funding round will further solidify Even Healthcare’s position as a leader in India’s rapidly evolving healthcare sector, enabling it to continue delivering high-quality, affordable healthcare to its growing membership base.

The post Even Healthcare Secures $30M in Series A Funding to Revolutionize Healthcare in India appeared first on The India Bizz Startup News Website.

The post Even Healthcare Secures $30M in Series A Funding to Revolutionize Healthcare in India appeared first on The India Bizz Startup News Website.

Mumbai: LordsMed has launched a set of 10 world-class reagents for triglycerides, uric acid, alkaline phosphatase, bilirubin, calcium (Arsenazo III), creatinine, glucose, serum glutamic oxaloacetic transaminase (SGOT)/aspartate aminotransferas, serum glutamic pyruvic transaminase (SGPT), alanine aminotransferase (ALT) and total protein.

These reagents come with 99.7 per cent accuracy, the highest level of sensitivity, a shelf-life of 24 months, unique packaging, and competitive price points. The company has filed India patents for these reagents, which will strengthen the preventive healthcare mechanism for critical diseases.

The company will manufacture these reagents at its manufacturing facility in Maharashtra and make these reagents available to pathological labs, hospitals, and research institutes through its pan-India distribution network of over 300 dealers. LordsMed will use the reagents in its chain of pathological labs as well.

The company has plans to export the reagent to key global markets. LordsMed aims to generate revenue by supplying these reagents pan-India and within SAARC, African, and Eastern European countries in global markets within a couple of years.

Commenting on the launch, Sachidanand Upadhyay, MD & CEO, Lord’s Mark Industries Ltd, said, “The demand for affordable and quality reagent in India is growing steadily on the back of prevalence of chronic and infectious diseases, growing awareness of importance of diagnostic intervention and the benefits of preventive healthcare.”

LordsMed has its manufacturing facility at Vasai, and the company is currently in the final stage of establishing its second and third manufacturing facilities in Lucknow, Uttar Pradesh, and Silvassa, Union Territory of Dadra & Nagar Haveli, respectively.

The post LordsMed launches set of 10 biochemistry reagents appeared first on The India Bizz Startup News Website.

The post LordsMed launches set of 10 biochemistry reagents appeared first on The India Bizz Startup News Website.

These re-agent and diagnostic test kits come with 99.7 percent accuracy, the highest level of sensitivity, a shelf-life of 24 months, unique packaging and competitive price-points. The company has filed India patents for these kits which will strengthen the preventive healthcare mechanism for critical diseases.

LordsMed will manufacture these re-agent and diagnostic testing kits at its manufacturing facility in Maharashtra and make these kits available to pathological labs, hospitals and research institutes through its Pan-India distribution network of over 300 dealers. LordsMed will use the kits in its chain of pathological labs as well.

The company has plans to export the re-agent and kits in key global markets. LordsMed aims to generate revenue worth Rs.200 crores by supplying these kits Pan India and within SAARC, African and Eastern Europe countries in global markets within couple of years.

Commenting on the launch, Sachidanand Upadhyay, MD & CEO, Lord’s Mark Industries Ltd. said, “The demand for affordable and quality re-agent and diagnostic kits in India is growing steadily on the back of prevalence of chronic and infectious diseases, growing awareness of importance of diagnostic intervention and the benefits of preventive healthcare.

Our reList of Pharma Companies in Mumbaiagent or diagnostic testing kits with unparalleled accuracy, sensitivity and shelf life will redefine the pre-emptive diagnostic interventions framework for critical diseases. As Indian patents are recognized globally, we have filed India patents for our kits to get easy acceptance in global markets. With our robust manufacturing capacity and domestic and global distribution network, we are working towards meeting the growing demand for quality diagnostic kits across regions.”

LordsMed has its manufacturing facility at Vasai and the company is currently in the final stage of establishing its second and third manufacturing facilities in Lucknow, Uttar Pradesh, and Silvassa, Union Territory of Dadra & Nagar Haveli respectively. These facilities are poised to set new benchmarks in Asia, in terms of production capacity and quality standards.

Lords Mark Industries has entered into technological tie-ups with IIT Bombay, Bhabha Atomic Research Centre (BARC) and other premier institutes to develop world-class patent products which will change the face of the diagnostic industry. Lords Mark Industries is working towards developing affordable non-invasive diagnostic kits with the highest accuracy level for critical diseases such as sickle cell, oral cancer and tuberculosis. 

About Lord’s Mark Industries

Incorporated in 1998, Lord’s Mark Industries Private Ltd. (Lord’s) has made impressive growth starting from paper to LED to Renewable energy and making grand in the medical diagnostic industry. Lord’s and its subsidiaries have made a mark in Electric Vehicle, Genome Testing, Vitamin Industry and Healthcare. Growth through diversification has become the trend setter and has been the cornerstone of success at Lord’s.
 

For more information, please visit lordsmark.com.

The post LordsMark Industries Launches Bio-Chemistry Reagents For Advanced Diagnostics appeared first on The India Bizz Startup News Website.

The post LordsMark Industries Launches Bio-Chemistry Reagents For Advanced Diagnostics appeared first on The India Bizz Startup News Website.